Actress and author Tori Spelling and her daughter Stella McDermott have shared their struggles with eczema in a recent interview. Eczema is a group of inflammatory skin conditions that affects a significant portion of the population worldwide. Spelling and McDermott have partnered with Arcutis Biotherapeutics, Inc. for the “Free To Be Me” campaign to raise awareness and reduce stigma surrounding inflammatory skin conditions.
Spelling revealed that she was not fully aware of eczema until she experienced it herself as an adult. Stress was a significant factor in triggering her eczema symptoms. On the other hand, McDermott has been dealing with eczema since early childhood, facing challenges such as bullying due to the condition.
Both Spelling and McDermott tried various treatments for eczema, with mixed results. They eventually found relief with Zoryve, a topical medication from Arcutis Biotherapeutics, Inc. that does not contain steroids. The active ingredient in Zoryve, roflumilast, targets the inflammatory response seen in eczema by inhibiting phosphodiesterase-4 activity.
Dr. Adam Friedman emphasized the importance of personalized treatment options for eczema and the advancements in targeted therapies available today. It is crucial to consult with a healthcare professional to determine the most suitable treatment for individual cases of eczema.
Spelling is now actively involved in podcasts and other projects, while McDermott is enjoying her senior year and looking forward to upcoming milestones. The journey with eczema has been challenging, but finding an effective treatment has made a significant difference in their lives.
